Pharmalegacy

澎立生物

Pharmalegacy

Biotech/Healthcare

Founded in 2008, Pengli Bio is a leading Chinese provider of comprehensive preclinical pharmacology, pharmacodynamic evaluation, and bioanalysis services. It operates China's most complete immune-inflammation pharmacology evaluation platform, an internationally leading non-human primate…

Latest round: Strategic (2021)

Source: ChinaBulls — chinabulls.com

Last updated 2021-10-01